| Chemical and biomolecular strategies for STING pathway activation in cancer immunotherapy KM Garland, TL Sheehy, JT Wilson Chemical reviews 122 (6), 5977-6039, 2022 | 197 | 2022 |
| Potent STING activation stimulates immunogenic cell death to enhance antitumor immunity in neuroblastoma L Wang-Bishop, M Wehbe, D Shae, J James, BC Hacker, K Garland, ... Journal for immunotherapy of cancer 8 (1), 2020 | 138 | 2020 |
| STING-activating nanoparticles normalize the vascular-immune interface to potentiate cancer immunotherapy L Wang-Bishop, BR Kimmel, VM Ngwa, MZ Madden, JJ Baljon, ... Science immunology 8 (83), eadd1153, 2023 | 47 | 2023 |
| A nanovaccine for enhancing cellular immunity via cytosolic co-delivery of antigen and polyIC RNA CS Carson, KW Becker, KM Garland, HM Pagendarm, PT Stone, K Arora, ... Journal of Controlled Release 345, 354-370, 2022 | 23 | 2022 |
| Pharmacological activation of cGAS for cancer immunotherapy KM Garland, JC Rosch, CS Carson, L Wang-Bishop, A Hanna, S Sevimli, ... Frontiers in Immunology 12, 753472, 2021 | 21 | 2021 |
| Microparticle depots for controlled and sustained release of endosomolytic nanoparticles KM Garland, S Sevimli, KV Kilchrist, CL Duvall, RS Cook, JT Wilson Cellular and Molecular Bioengineering 12, 429-442, 2019 | 14 | 2019 |
| Nanoparticle Retinoic Acid-Inducible Gene I Agonist for Cancer Immunotherapy L Wang-Bishop, M Wehbe, LE Pastora, J Yang, BR Kimmel, KM Garland, ... ACS nano 18 (18), 11631-11643, 2024 | 4 | 2024 |
| Nanoparticle delivery of immunostimulatory Alu RNA for cancer immunotherapy KM Garland, AJ Kwiatkowski, JT Tossberg, PS Crooke III, TM Aune, ... Cancer Research Communications 3 (9), 1800-1809, 2023 | 2 | 2023 |
| A Nanoparticle RIG-I Agonist for Cancer Immunotherapy L Wang-Bishop, M Wehbe, LE Pastora, J Yang, KM Garland, KW Becker, ... bioRxiv, 2023.04. 25.537919, 2023 | | 2023 |
| Engineering Innate Immune Activators for Intratumoral Immunotherapy KM Garland | | 2021 |